The Monoacylglycerol Acyltransferase Pathway Contributes to Triacylglycerol Synthesis in HepG2 Cells

Overview

Journal Sci Rep

Specialty Science

Date 2022 Mar 24

PMID 35322811

Authors

Pamela J McFie

Apurv Patel

Scot J Stone

Affiliations

Soon will be listed here.

Abstract

The monoacylglycerol acyltransferase (MGAT) pathway has a well-established role in the small intestine where it facilitates the absorption of dietary fat. In enterocytes, MGAT participates in the resynthesis of triacylglycerol using substrates (monoacylglycerol and fatty acids) generated in the gut lumen from the breakdown of triacylglycerol consumed in the diet. MGAT activity is also present in the liver, but its role in triacylglycerol metabolism in this tissue remains unclear. The predominant MGAT isoforms present in human liver appear to be MGAT2 and MGAT3. The objective of this study was to use selective small molecule inhibitors of MGAT2 and MGAT3 to determine the contributions of these enzymes to triacylglycerol production in liver cells. We found that pharmacological inhibition of either enzyme had no effect on TG mass in HepG2 cells but did alter lipid droplet size and number. Inhibition of MGAT2 did result in decreased DG and TG synthesis and TG secretion. Interestingly, MGAT2 preferentially utilized 2-monoacylglycerol derived from free glycerol and not from exogenously added 2-monoacylglycerol. In contrast, inhibition of MGAT3 had very little effect on TG metabolism in HepG2 cells. Additionally, we demonstrated that the MGAT activity of DGAT1 only makes a minor contribution to TG synthesis in intact HepG2 cells. Our data demonstrated that the MGAT pathway has a role in hepatic lipid metabolism with MGAT2, more so than MGAT3, contributing to TG synthesis and secretion.

Citing Articles

Leonurine Inhibits Hepatic Lipid Synthesis to Ameliorate NAFLD via the ADRA1a/AMPK/SCD1 Axis.

Fan W, Pan M, Zheng C, Shen H, Pi D, Song Q Int J Mol Sci. 2024; 25(19).

PMID: 39409181 PMC: 11476755. DOI: 10.3390/ijms251910855.

Identification of genomic regions associated with fatty acid metabolism across blood, liver, backfat and muscle in pigs.

Liu J, Sebastia C, Jove-Junca T, Quintanilla R, Gonzalez-Rodriguez O, Passols M Genet Sel Evol. 2024; 56(1):66.

PMID: 39327557 PMC: 11426007. DOI: 10.1186/s12711-024-00933-3.

Integrated Lipidomics and Transcriptomics Analyses Reveal Key Regulators of Fat Deposition in Different Adipose Tissues of Geese ().

Xu M, Zhang Y, Zhang Y, Xu Q, Zhang Y, Chen G Animals (Basel). 2024; 14(13).

PMID: 38998104 PMC: 11240315. DOI: 10.3390/ani14131990.

Serotonin Transporter Deficiency Induces Metabolic Alterations in the Ileal Mucosa.

Calzadilla N, Jayawardena D, Qazi A, Sharma A, Mongan K, Comiskey S Int J Mol Sci. 2024; 25(8).

PMID: 38674044 PMC: 11049861. DOI: 10.3390/ijms25084459.

The chylomicron saga: time to focus on postprandial metabolism.

Gugliucci A Front Endocrinol (Lausanne). 2024; 14:1322869.

PMID: 38303975 PMC: 10830840. DOI: 10.3389/fendo.2023.1322869.

References

Coleman R, Haynes E, Coats C . Ontogeny of microsomal activities of triacylglycerol synthesis in guinea pig liver. J Lipid Res. 1987; 28(3):320-5. View

Okuma C, Ohta T, Tadaki H, Hamada H, Oda T, Taniuchi H . JTP-103237, a novel monoacylglycerol acyltransferase inhibitor, modulates fat absorption and prevents diet-induced obesity. Eur J Pharmacol. 2015; 758:72-81. DOI: 10.1016/j.ejphar.2015.03.072. View

BLIGH E, Dyer W . A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959; 37(8):911-7. DOI: 10.1139/o59-099. View

Dow R, Li J, Pence M, Gibbs E, LaPerle J, Litchfield J . Discovery of PF-04620110, a Potent, Selective, and Orally Bioavailable Inhibitor of DGAT-1. ACS Med Chem Lett. 2014; 2(5):407-12. PMC: 4018057. DOI: 10.1021/ml200051p. View

Cases S, Smith S, Zheng Y, MYERS H, Lear S, Sande E . Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc Natl Acad Sci U S A. 1998; 95(22):13018-23. PMC: 23692. DOI: 10.1073/pnas.95.22.13018. View

Cases S, Stone S, Zhou P, Yen E, Tow B, Lardizabal K . Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J Biol Chem. 2001; 276(42):38870-6. DOI: 10.1074/jbc.M106219200. View

Han G, Wu W, Carman G . The Saccharomyces cerevisiae Lipin homolog is a Mg2+-dependent phosphatidate phosphatase enzyme. J Biol Chem. 2006; 281(14):9210-8. PMC: 1424669. DOI: 10.1074/jbc.M600425200. View

Tsai J, Qiu W, Kohen-Avramoglu R, Adeli K . MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly. Arterioscler Thromb Vasc Biol. 2006; 27(1):211-8. DOI: 10.1161/01.ATV.0000249861.80471.96. View

Yen C, Farese Jr R . MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine. J Biol Chem. 2003; 278(20):18532-7. DOI: 10.1074/jbc.M301633200. View

10.

Cheng D, Nelson T, Chen J, Walker S, Wardwell-Swanson J, Meegalla R . Identification of acyl coenzyme A:monoacylglycerol acyltransferase 3, an intestinal specific enzyme implicated in dietary fat absorption. J Biol Chem. 2003; 278(16):13611-4. DOI: 10.1074/jbc.C300042200. View

11.

Lutkewitte A, Singer J, Shew T, Martino M, Hall A, He M . Multiple antisense oligonucleotides targeted against monoacylglycerol acyltransferase 1 (Mogat1) improve glucose metabolism independently of Mogat1. Mol Metab. 2021; 49:101204. PMC: 8027266. DOI: 10.1016/j.molmet.2021.101204. View

12.

Meex S, Andreo U, Sparks J, Fisher E . Huh-7 or HepG2 cells: which is the better model for studying human apolipoprotein-B100 assembly and secretion?. J Lipid Res. 2010; 52(1):152-8. PMC: 2999930. DOI: 10.1194/jlr.D008888. View

13.

Vance J . Phospholipid synthesis in a membrane fraction associated with mitochondria. J Biol Chem. 1990; 265(13):7248-56. View

14.

Sato K, Takahagi H, Yoshikawa T, Morimoto S, Takai T, Hidaka K . Discovery of a Novel Series of N-Phenylindoline-5-sulfonamide Derivatives as Potent, Selective, and Orally Bioavailable Acyl CoA:Monoacylglycerol Acyltransferase-2 Inhibitors. J Med Chem. 2015; 58(9):3892-909. DOI: 10.1021/acs.jmedchem.5b00178. View

15.

Coleman R, Lee D . Enzymes of triacylglycerol synthesis and their regulation. Prog Lipid Res. 2003; 43(2):134-76. DOI: 10.1016/s0163-7827(03)00051-1. View

16.

Liguori M, Blomme E, Waring J . Trovafloxacin-induced gene expression changes in liver-derived in vitro systems: comparison of primary human hepatocytes to HepG2 cells. Drug Metab Dispos. 2007; 36(2):223-33. DOI: 10.1124/dmd.107.017608. View

17.

Buhman K, Smith S, Stone S, Repa J, Wong J, Knapp Jr F . DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis. J Biol Chem. 2002; 277(28):25474-9. DOI: 10.1074/jbc.M202013200. View

18.

Younossi Z, Koenig A, Abdelatif D, Fazel Y, Henry L, Wymer M . Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2015; 64(1):73-84. DOI: 10.1002/hep.28431. View

19.

Reue K, Zhang P . The lipin protein family: dual roles in lipid biosynthesis and gene expression. FEBS Lett. 2007; 582(1):90-6. PMC: 2848953. DOI: 10.1016/j.febslet.2007.11.014. View

20.

Yang L, Kuksis A . Apparent convergence (at 2-monoacylglycerol level) of phosphatidic acid and 2-monoacylglycerol pathways of synthesis of chylomicron triacylglycerols. J Lipid Res. 1991; 32(7):1173-86. View